
Innovative therapies and devices are transforming food allergy management, enhancing safety and quality of life for patients and families.

Edwin H. Kim, MD, is an associate professor of pediatrics at University of North Carolina’s School of Medicine.

Innovative therapies and devices are transforming food allergy management, enhancing safety and quality of life for patients and families.

Kim, Sindher, Huffaker spoke with HCPLive about some of the year’s most important developments in the food allergy space, namely the approvals of omalizumab and neffy.